David C. Murray

6.0k total citations · 2 hit papers
34 papers, 4.7k citations indexed

About

David C. Murray is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David C. Murray has authored 34 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 9 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David C. Murray's work include Dialysis and Renal Disease Management (11 papers), Cardiovascular Function and Risk Factors (8 papers) and Heart Failure Treatment and Management (7 papers). David C. Murray is often cited by papers focused on Dialysis and Renal Disease Management (11 papers), Cardiovascular Function and Risk Factors (8 papers) and Heart Failure Treatment and Management (7 papers). David C. Murray collaborates with scholars based in United States, Canada and New Zealand. David C. Murray's co-authors include Gloria M. Kent, Paul E. Barré, John D. Harnett, Robert N. Foley, Patrick S. Parfrey, Christopher J. Martin, Patrick S. Parfrey, Ronald D. Guttmann, John D. Harriett and Bruce F. Culleton and has published in prestigious journals such as The Journal of Physiology, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

David C. Murray

33 papers receiving 4.5k citations

Hit Papers

Clinical and echocardiographic disease in patients starti... 1995 2026 2005 2015 1995 1996 250 500 750 1000

Peers

David C. Murray
Gavin J. Becker Australia
Stephen G. Rostand United States
Theodore I. Steinman United States
Jay L. Xue United States
Ercan Ok Türkiye
Katharine A. Kirk United States
Adrian Spitzer United States
Gavin J. Becker Australia
David C. Murray
Citations per year, relative to David C. Murray David C. Murray (= 1×) peers Gavin J. Becker

Countries citing papers authored by David C. Murray

Since Specialization
Citations

This map shows the geographic impact of David C. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Murray more than expected).

Fields of papers citing papers by David C. Murray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Murray. The network helps show where David C. Murray may publish in the future.

Co-authorship network of co-authors of David C. Murray

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Murray. A scholar is included among the top collaborators of David C. Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Murray. David C. Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spear, Timothy T., et al.. (2017). HCV T Cell Receptor Chain Modifications to Enhance Expression, Pairing, and Antigen Recognition in T Cells for Adoptive Transfer. Molecular Therapy — Oncolytics. 5. 105–115. 16 indexed citations
2.
Spear, Timothy T., Yuan Wang, David C. Murray, et al.. (2017). Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells. Cancer Immunology Immunotherapy. 66(11). 1411–1424. 15 indexed citations
3.
Spear, Timothy T., Glenda G. Callender, J. Roszkowski, et al.. (2016). TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors. Cancer Immunology Immunotherapy. 65(3). 293–304. 45 indexed citations
4.
Foley, Robert N., Patrick S. Parfrey, Gloria M. Kent, et al.. (2000). Serial Change in Echocardiographic Parameters and Cardiac Failure in End-Stage Renal Disease. Journal of the American Society of Nephrology. 11(5). 912–916. 188 indexed citations
5.
Parfrey, Patrick S., et al.. (1998). Long-term evolution of cardiomyopathy in dialysis patients. Kidney International. 54(5). 1720–1725. 172 indexed citations
6.
Foley, Robert N., Bruce F. Culleton, Patrick S. Parfrey, et al.. (1997). Cardiac disease in diabetic end-stage renal disease. Diabetologia. 40(11). 1307–1312. 95 indexed citations
7.
Keef, Kathleen D., David C. Murray, Kerrie M. Sanders, & Terence K. Smith. (1997). Basal release of nitric oxide induces an oscillatory motor pattern in canine colon.. The Journal of Physiology. 499(3). 773–786. 52 indexed citations
8.
Brady, A.M., Andy Greenland, S. P. Heaney, et al.. (1997). RATIONALE AND PERSPECTIVES ON THE DEVELOPMENT OF FUNGICIDES. Annual Review of Phytopathology. 35(1). 349–372. 143 indexed citations
9.
Foley, Robert N., Patrick S. Parfrey, John D. Harnett, et al.. (1996). Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney International. 49(5). 1379–1385. 378 indexed citations
10.
Harriett, John D., et al.. (1996). Hypocalcemia, Morbidity, and Mortality in End-Stage Renal Disease. American Journal of Nephrology. 16(5). 386–393. 87 indexed citations
11.
Foley, Robert N., Patrick S. Parfrey, John D. Harnett, et al.. (1996). The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. American Journal of Kidney Diseases. 28(1). 53–61. 608 indexed citations breakdown →
12.
Parfrey, Patrick S., John D. Harnett, Robert N. Foley, et al.. (1995). IMPACT OF RENAL TRANSPLANTATION ON UREMIC CARDIOMYOPATHY. Transplantation. 60(11). 908–913. 137 indexed citations
13.
Foley, Robert N., Patrick S. Parfrey, John D. Harnett, et al.. (1995). Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney International. 47(1). 186–192. 1006 indexed citations breakdown →
14.
Murray, David C., et al.. (1994). Health Care Reform, Regulation, and innovation in the Medical Device industry : A Study of Competitiveness in a Vital U.S. Industry. 1 indexed citations
15.
Thomas, J. Hywel, David C. Murray, & Paul Sharp. (1992). Diabetes altars the cyclic AMP response of isolated renal glomeruli. Biochemical Society Transactions. 20(2). 132S–132S. 1 indexed citations
16.
Murray, David C., Peter Hoban, W. Howell Round, Ian D. Graham, & Peter Metcalfe. (1991). Superposition on a multicomputer system. Medical Physics. 18(3). 468–473. 7 indexed citations
17.
Metcalfe, Peter, Peter Hoban, David C. Murray, & W. Howell Round. (1990). Beam hardening of 10 MV radiotherapy X-rays: analysis using a convolution/superposition method. Physics in Medicine and Biology. 35(11). 1533–1549. 22 indexed citations
18.
Hoban, Peter, David C. Murray, Peter Metcalfe, & W. Howell Round. (1990). Superposition dose calculation in lung for 10MV photons.. PubMed. 13(2). 81–92. 12 indexed citations
20.
Murray, David C.. (1973). Suicidal and Depressive Feelings among College Students. Psychological Reports. 33(1). 175–181. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026